- Home
- TORO vs CASI Comparison
TORO vs CASI Comparison
Compare TORO & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TORO
- CASI
- Stock Information
- Founded
- TORO 2022
- CASI 1991
- Country
- TORO Cyprus
- CASI China
- Employees
- TORO N/A
- CASI N/A
- Industry
- TORO Marine Transportation
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- TORO Consumer Discretionary
- CASI Health Care
- Exchange
- TORO Nasdaq
- CASI Nasdaq
- Market Cap
- TORO 58.6M
- CASI 58.8M
- IPO Year
- TORO N/A
- CASI 1996
- Fundamental
- Price
- TORO $2.80
- CASI $2.37
- Analyst Decision
- TORO
- CASI Strong Buy
- Analyst Count
- TORO 0
- CASI 1
- Target Price
- TORO N/A
- CASI $6.00
- AVG Volume (30 Days)
- TORO 35.5K
- CASI 30.6K
- Earning Date
- TORO 02-10-2025
- CASI 11-15-2024
- Dividend Yield
- TORO N/A
- CASI N/A
- EPS Growth
- TORO N/A
- CASI N/A
- EPS
- TORO 0.99
- CASI N/A
- Revenue
- TORO $80,626,531.00
- CASI $22,055,000.00
- Revenue This Year
- TORO N/A
- CASI N/A
- Revenue Next Year
- TORO N/A
- CASI $134.79
- P/E Ratio
- TORO $0.99
- CASI N/A
- Revenue Growth
- TORO 52.03
- CASI N/A
- 52 Week Low
- TORO $2.25
- CASI $2.05
- 52 Week High
- TORO $6.45
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- TORO 41.55
- CASI 33.86
- Support Level
- TORO $2.71
- CASI $2.44
- Resistance Level
- TORO $3.49
- CASI $2.73
- Average True Range (ATR)
- TORO 0.19
- CASI 0.26
- MACD
- TORO -0.05
- CASI 0.03
- Stochastic Oscillator
- TORO 11.54
- CASI 10.92
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.